Canada Pension Plan Investment Board
MYGN icon

Canada Pension Plan Investment Board’s Myriad Genetics MYGN Stock Holding History

Canada Pension Plan Investment Board’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$790K Buy
138,400
+400
+0.3% +$1.82K ﹤0.01% 1092
2026
Q1 		$621K Sell
138,000
-298,900
-68% -$1.56M ﹤0.01% 1158
2025
Q4 		$2.69M Buy
436,900
+128,800
+42% +$934K ﹤0.01% 886
2025
Q3 		$2.23M Hold
308,100
– – ﹤0.01% 902
2025
Q2 		$1.64M Buy
+308,100
New +$1.82M ﹤0.01% 906
2020
Q3 		– Sell
-125,745
Closed -$1.43M – 1255
2020
Q2 		$1.43M Buy
125,745
+13,700
+12% +$195K ﹤0.01% 834
2020
Q1 		$1.6M Buy
112,045
+57,200
+104% +$1.21M ﹤0.01% 773
2019
Q4 		$1.49M Buy
+54,845
New +$1.51M ﹤0.01% 930
2019
Q1 		– Sell
-4,100
Closed -$119K – 1595
2018
Q4 		$119K Sell
4,100
-101,400
-96% -$3.65M ﹤0.01% 1192
2018
Q3 		$4.85M Sell
105,500
-20,000
-16% -$889K 0.01% 825
2018
Q2 		$4.69M Sell
125,500
-434,000
-78% -$14.7M 0.01% 806
2018
Q1 		$16.5M Buy
559,500
+9,000
+2% +$305K 0.03% 465
2017
Q4 		$18.9M Buy
550,500
+374,900
+213% +$12.6M 0.04% 384
2017
Q3 		$6.35M Sell
175,600
-195,100
-53% -$5.56M 0.01% 613
2017
Q2 		$9.58M Sell
370,700
-412,400
-53% -$8.75M 0.02% 504
2017
Q1 		$15M Sell
783,100
-63,100
-7% -$1.12M 0.04% 357
2016
Q4 		$14.1M Buy
846,200
+60,000
+8% +$1.09M 0.05% 265
2016
Q3 		$16.2M Buy
786,200
+437,900
+126% +$11.1M 0.06% 250
2016
Q2 		$10.7M Buy
348,300
+165,700
+91% +$5.76M 0.04% 331
2016
Q1 		$6.83M Buy
182,600
+181,400
+15,117% +$6.84M 0.03% 472
2015
Q4 		$52K Sell
1,200
-1,400
-54% -$59.1K ﹤0.01% 1136
2015
Q3 		$97K Buy
2,600
+600
+30% +$21.3K ﹤0.01% 1115
2015
Q2 		$68K Buy
+2,000
New +$68K ﹤0.01% 1164
2014
Q1 		– Sell
-36,100
Closed -$757K – 1327
2013
Q4 		$757K Buy
+36,100
New +$913K ﹤0.01% 837
2013
Q3 		– Sell
-400
Closed -$11K – 1173
2013
Q2 		$11K Buy
+400
New +$11.6K ﹤0.01% 905

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Canada Pension Plan Investment Board's MYGN Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Myriad Genetics (MYGN) stake by 0.29% in Q2 2026, buying an estimated $1.82K and bringing the position to 138,400 shares worth $790K. The position accounts for ﹤0.01% of the portfolio, ranked #1092.

Canada Pension Plan Investment Board first reported a position in MYGN in Q2 2013 and has held it in 25 quarters since. The position peaked at $18.9M in Q4 2017. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Canada Pension Plan Investment Board held 138,400 shares of Myriad Genetics worth $790K as of Q2 2026.
  • Canada Pension Plan Investment Board bought 400 Myriad Genetics shares in Q2 2026, an estimated $1.82K.
  • Myriad Genetics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1092 holding.
  • Canada Pension Plan Investment Board first reported a position in Myriad Genetics in Q2 2013 and has held it in 25 quarters since.
  • Canada Pension Plan Investment Board's Myriad Genetics position peaked at $18.9M in Q4 2017.
  • 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.